3.19.1 html 359 269 1 false 84 0 false 8 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.arraybiopharma.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.arraybiopharma.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.arraybiopharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.arraybiopharma.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 1003000 - Statement - Condensed Consolidated Statement of Stockholders' Equity Sheet http://www.arraybiopharma.com/role/CondensedConsolidatedStatementOfStockholdersEquity Condensed Consolidated Statement of Stockholders' Equity Statements 5 false false R6.htm 1004000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.arraybiopharma.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 2101100 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.arraybiopharma.com/role/OverviewBasisOfPresentationAndSummaryOfSignificantAccountingPolicies OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 2102100 - Disclosure - MARKETABLE SECURITIES Sheet http://www.arraybiopharma.com/role/MarketableSecurities MARKETABLE SECURITIES Notes 8 false false R9.htm 2103100 - Disclosure - PRODUCT REVENUE (Notes) Notes http://www.arraybiopharma.com/role/ProductRevenueNotes PRODUCT REVENUE (Notes) Notes 9 false false R10.htm 2104100 - Disclosure - COLLABORATION AND OTHER AGREEMENTS Sheet http://www.arraybiopharma.com/role/CollaborationAndOtherAgreements COLLABORATION AND OTHER AGREEMENTS Notes 10 false false R11.htm 2105100 - Disclosure - DEBT Sheet http://www.arraybiopharma.com/role/Debt DEBT Notes 11 false false R12.htm 2106100 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.arraybiopharma.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 12 false false R13.htm 2107100 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.arraybiopharma.com/role/StockholdersEquity STOCKHOLDERS' EQUITY Notes 13 false false R14.htm 2108100 - Disclosure - SHARE-BASED COMPENSATION Sheet http://www.arraybiopharma.com/role/ShareBasedCompensation SHARE-BASED COMPENSATION Notes 14 false false R15.htm 2109100 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.arraybiopharma.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 15 false false R16.htm 2110100 - Disclosure - NET LOSS PER SHARE Sheet http://www.arraybiopharma.com/role/NetLossPerShare NET LOSS PER SHARE Notes 16 false false R17.htm 2201201 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.arraybiopharma.com/role/OverviewBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 17 false false R18.htm 2301302 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.arraybiopharma.com/role/OverviewBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.arraybiopharma.com/role/OverviewBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 18 false false R19.htm 2302301 - Disclosure - MARKETABLE SECURITIES (Tables) Sheet http://www.arraybiopharma.com/role/MarketableSecuritiesTables MARKETABLE SECURITIES (Tables) Tables http://www.arraybiopharma.com/role/MarketableSecurities 19 false false R20.htm 2303301 - Disclosure - PRODUCT REVENUE (Tables) Sheet http://www.arraybiopharma.com/role/ProductRevenueTables PRODUCT REVENUE (Tables) Tables http://www.arraybiopharma.com/role/ProductRevenueNotes 20 false false R21.htm 2304301 - Disclosure - COLLABORATION AND OTHER AGREEMENTS (Tables) Sheet http://www.arraybiopharma.com/role/CollaborationAndOtherAgreementsTables COLLABORATION AND OTHER AGREEMENTS (Tables) Tables http://www.arraybiopharma.com/role/CollaborationAndOtherAgreements 21 false false R22.htm 2305301 - Disclosure - DEBT (Tables) Sheet http://www.arraybiopharma.com/role/DebtTables DEBT (Tables) Tables http://www.arraybiopharma.com/role/Debt 22 false false R23.htm 2306301 - Disclosure - FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.arraybiopharma.com/role/FairValueMeasurementsFairValueMeasurementsTables FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS (Tables) Tables 23 false false R24.htm 2308301 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://www.arraybiopharma.com/role/ShareBasedCompensationTables SHARE-BASED COMPENSATION (Tables) Tables http://www.arraybiopharma.com/role/ShareBasedCompensation 24 false false R25.htm 2310301 - Disclosure - NET LOSS PER SHARE (Tables) Sheet http://www.arraybiopharma.com/role/NetLossPerShareTables NET LOSS PER SHARE (Tables) Tables http://www.arraybiopharma.com/role/NetLossPerShare 25 false false R26.htm 2401403 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration of Revenue (Details) Sheet http://www.arraybiopharma.com/role/OverviewBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesScheduleOfConcentrationOfRevenueDetails OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration of Revenue (Details) Details 26 false false R27.htm 2401404 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Revenue by Geographic Area (Details) Sheet http://www.arraybiopharma.com/role/OverviewBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByGeographicAreaDetails OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Revenue by Geographic Area (Details) Details 27 false false R28.htm 2401405 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) Sheet http://www.arraybiopharma.com/role/OverviewBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) Details 28 false false R29.htm 2402402 - Disclosure - MARKETABLE SECURITIES - Schedule of Marketable Securities (Details) Sheet http://www.arraybiopharma.com/role/MarketableSecuritiesScheduleOfMarketableSecuritiesDetails MARKETABLE SECURITIES - Schedule of Marketable Securities (Details) Details 29 false false R30.htm 2402403 - Disclosure - MARKETABLE SECURITIES - Schedule of Amortized Cost And Estimated Fair Value (Details) Sheet http://www.arraybiopharma.com/role/MarketableSecuritiesScheduleOfAmortizedCostAndEstimatedFairValueDetails MARKETABLE SECURITIES - Schedule of Amortized Cost And Estimated Fair Value (Details) Details 30 false false R31.htm 2403402 - Disclosure - PRODUCT REVENUE - Net Product Revenue (Details) Sheet http://www.arraybiopharma.com/role/ProductRevenueNetProductRevenueDetails PRODUCT REVENUE - Net Product Revenue (Details) Details 31 false false R32.htm 2403403 - Disclosure - PRODUCT REVENUE - Schedule of Allowances for Sales (Details) Sheet http://www.arraybiopharma.com/role/ProductRevenueScheduleOfAllowancesForSalesDetails PRODUCT REVENUE - Schedule of Allowances for Sales (Details) Details 32 false false R33.htm 2403404 - Disclosure - PRODUCT REVENUE - Narrative (Details) Sheet http://www.arraybiopharma.com/role/ProductRevenueNarrativeDetails PRODUCT REVENUE - Narrative (Details) Details 33 false false R34.htm 2404402 - Disclosure - COLLABORATION AND OTHER AGREEMENTS - Schedule of Total Revenue (Details) Sheet http://www.arraybiopharma.com/role/CollaborationAndOtherAgreementsScheduleOfTotalRevenueDetails COLLABORATION AND OTHER AGREEMENTS - Schedule of Total Revenue (Details) Details 34 false false R35.htm 2404403 - Disclosure - COLLABORATION AND OTHER AGREEMENTS - Schedule of Deferred Revenue (Details) Sheet http://www.arraybiopharma.com/role/CollaborationAndOtherAgreementsScheduleOfDeferredRevenueDetails COLLABORATION AND OTHER AGREEMENTS - Schedule of Deferred Revenue (Details) Details 35 false false R36.htm 2404404 - Disclosure - COLLABORATION AND OTHER AGREEMENTS - Additional Information (Details) Sheet http://www.arraybiopharma.com/role/CollaborationAndOtherAgreementsAdditionalInformationDetails COLLABORATION AND OTHER AGREEMENTS - Additional Information (Details) Details 36 false false R37.htm 2405402 - Disclosure - DEBT - Schedule of Debt (Details) Sheet http://www.arraybiopharma.com/role/DebtScheduleOfDebtDetails DEBT - Schedule of Debt (Details) Details 37 false false R38.htm 2405403 - Disclosure - DEBT - Redmile Notes Payable (Details) Notes http://www.arraybiopharma.com/role/DebtRedmileNotesPayableDetails DEBT - Redmile Notes Payable (Details) Details 38 false false R39.htm 2405404 - Disclosure - DEBT - Silicon Valley Bank Term Loan (Details) Sheet http://www.arraybiopharma.com/role/DebtSiliconValleyBankTermLoanDetails DEBT - Silicon Valley Bank Term Loan (Details) Details 39 false false R40.htm 2405405 - Disclosure - DEBT - 2.65% Convertible Senior Notes Due 2024 (Details) Notes http://www.arraybiopharma.com/role/Debt265ConvertibleSeniorNotesDue2024Details DEBT - 2.65% Convertible Senior Notes Due 2024 (Details) Details 40 false false R41.htm 2405406 - Disclosure - DEBT - Summary of Interest Expense (Details) Sheet http://www.arraybiopharma.com/role/DebtSummaryOfInterestExpenseDetails DEBT - Summary of Interest Expense (Details) Details 41 false false R42.htm 2406402 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurements (Details) Sheet http://www.arraybiopharma.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementsDetails FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurements (Details) Details 42 false false R43.htm 2406403 - Disclosure - FAIR VALUE MEASUREMENTS - Rollforward of Change in Level 3 Financial Instruments (Details) Sheet http://www.arraybiopharma.com/role/FairValueMeasurementsRollforwardOfChangeInLevel3FinancialInstrumentsDetails FAIR VALUE MEASUREMENTS - Rollforward of Change in Level 3 Financial Instruments (Details) Details 43 false false R44.htm 2407401 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details) Sheet http://www.arraybiopharma.com/role/StockholdersEquityAdditionalInformationDetails STOCKHOLDERS' EQUITY - Additional Information (Details) Details 44 false false R45.htm 2408402 - Disclosure - SHARE-BASED COMPENSATION - Fair Value Assumptions (Details) Sheet http://www.arraybiopharma.com/role/ShareBasedCompensationFairValueAssumptionsDetails SHARE-BASED COMPENSATION - Fair Value Assumptions (Details) Details 45 false false R46.htm 2408403 - Disclosure - SHARE-BASED COMPENSATION - Summary of Stock Option Activity (Details) Sheet http://www.arraybiopharma.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetails SHARE-BASED COMPENSATION - Summary of Stock Option Activity (Details) Details 46 false false R47.htm 2408404 - Disclosure - SHARE-BASED COMPENSATION - Summary of RSUs (Details) Sheet http://www.arraybiopharma.com/role/ShareBasedCompensationSummaryOfRsusDetails SHARE-BASED COMPENSATION - Summary of RSUs (Details) Details 47 false false R48.htm 2408405 - Disclosure - SHARE-BASED COMPENSATION - Additional Information (Details) Sheet http://www.arraybiopharma.com/role/ShareBasedCompensationAdditionalInformationDetails SHARE-BASED COMPENSATION - Additional Information (Details) Details 48 false false R49.htm 2410402 - Disclosure - NET LOSS PER SHARE - Computation of Earnings Per Share (Details) Sheet http://www.arraybiopharma.com/role/NetLossPerShareComputationOfEarningsPerShareDetails NET LOSS PER SHARE - Computation of Earnings Per Share (Details) Details 49 false false R50.htm 2410403 - Disclosure - NET LOSS PER SHARE - Anti-dilutive Common Stock Equivalents (Details) Sheet http://www.arraybiopharma.com/role/NetLossPerShareAntiDilutiveCommonStockEquivalentsDetails NET LOSS PER SHARE - Anti-dilutive Common Stock Equivalents (Details) Details 50 false false All Reports Book All Reports arry-20190331.xml arry-20190331.xsd arry-20190331_cal.xml arry-20190331_def.xml arry-20190331_lab.xml arry-20190331_pre.xml http://fasb.org/us-gaap/2018-01-31 http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true